Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations.

Autor: Brastianos PK; Massachusetts General Hospital, Harvard Medical School, Boston, MA., Twohy EL; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN., Gerstner ER; Massachusetts General Hospital, Harvard Medical School, Boston, MA., Kaufmann TJ; Mayo Clinic, Rochester, MN., Iafrate AJ; Massachusetts General Hospital, Harvard Medical School, Boston, MA., Lennerz J; Massachusetts General Hospital, Harvard Medical School, Boston, MA., Jeyapalan S; Tufts Medical Center, Boston, MA., Piccioni DE; UC San Diego, San Diego, CA., Monga V; University of Iowa, Iowa City, IA., Fadul CE; University of Virginia Medical Center, Charlottesville, VA., Schiff D; University of Virginia Medical Center, Charlottesville, VA., Taylor JW; University of California, San Francisco Brain Tumor Center, San Francisco, CA., Chowdhary SA; Lynn Cancer Institute, Boca Raton Regional Hospital/Baptist Hospital South Florida, Boca Raton, FL., Bettegowda C; Johns Hopkins University School of Medicine, Baltimore, MD., Ansstas G; Washington University in St Louis, St Louis, MO., De La Fuente M; University of Miami Health System, Miami, FL., Anderson MD; University of Mississippi Medical Center, Jackson, MS., Shonka N; University of Nebraska Medical Center, Omaha, NE., Damek D; University of Colorado, Aurora, CO., Carrillo J; University of California Irvine, Irvine, CA., Kunschner-Ronan LJ; Dartmouth-Hitchcock Medical Center, Lebanon, NH., Chaudhary R; University of Cincinnati, West Chester, OH., Jaeckle KA; Mayo Clinic, Rochester, MN., Senecal FM; Northwest Medical Specialties, PLLC, Tacoma, WA., Kaley T; Memorial Sloan Kettering Cancer Center, New York, NY., Morrison T; Lehigh Valley Hospital-Cedar Crest, Allentown, PA., Thomas AA; University of Vermont, Burlington, VT., Welch MR; Columbia University Irving Medical Center, New York, NY., Iwamoto F; Columbia University Irving Medical Center, New York, NY., Cachia D; University of Massachusetts, Worcester, MA., Cohen AL; Inova Schar Cancer Institute, Fairfax, Virginia., Vora S; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Knopp M; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Dunn IF; College of Medicine, University of Oklahoma, Oklahoma City, OK., Kumthekar P; Northwestern University, Chicago, IL., Sarkaria J; Mayo Clinic, Rochester, MN., Geyer S; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN., Carrero XW; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN., Martinez-Lage M; Massachusetts General Hospital, Harvard Medical School, Boston, MA., Cahill DP; Massachusetts General Hospital, Harvard Medical School, Boston, MA., Brown PD; Mayo Clinic, Rochester, MN., Giannini C; Mayo Clinic, Rochester, MN., Santagata S; Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Barker FG 2nd; Massachusetts General Hospital, Harvard Medical School, Boston, MA., Galanis E; Mayo Clinic, Rochester, MN.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jan 20; Vol. 41 (3), pp. 618-628. Date of Electronic Publication: 2022 Oct 26.

Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review.

Autor: Belanger K; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, USA., Ung TH; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, USA., Damek D; Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA., Lillehei KO; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, USA., Ormond DR; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, USA. david.ormond@cuanschutz.edu.

Publikováno v: BMC cancer [BMC Cancer] 2022 Apr 07; Vol. 22 (1), pp. 367. Date of Electronic Publication: 2022 Apr 07.

Review of Novel Surgical, Radiation, and Systemic Therapies and Clinical Trials in Glioblastoma.

Autor: Valerius, Allison R.¹ (AUTHOR) sener.ugur@mayo.edu, Webb, Lauren M.¹ (AUTHOR), Thomsen, Anna¹ (AUTHOR), Lehrer, Eric J.² (AUTHOR), Breen, William G.² (AUTHOR), Campian, Jian L.³ (AUTHOR), Riviere-Cazaux, Cecile⁴ (AUTHOR), Burns, Terry C.⁴ (AUTHOR), Sener, Ugur^1,3 (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 19, p10570. 28p.

Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial.

Autor: Cloughesy TF; University of California, Los Angeles, Los Angeles, California., Petrecca K; Montreal Neurological Institute, Montreal, Quebec, Canada., Walbert T; Henry Ford Hospital, Detroit, Michigan., Butowski N; University of California, San Francisco, San Francisco, California., Salacz M; University of Kansas Medical Center, Kansas City, Kansas., Perry J; Sunnybrook Research Institute, Sunnybrook Hospital, Toronto, Canada., Damek D; University of Colorado, Aurora, Colorado., Bota D; University of California, Irvine, Irvine, California., Bettegowda C; Johns Hopkins University School of Medicine, Baltimore, Maryland., Zhu JJ; University of Texas Health Science Center, Houston, Texas., Iwamoto F; Columbia University, New York, New York., Placantonakis D; New York University Langone Medical Center, New York, New York., Kim L; Thomas Jefferson University, Philadelphia, Pennsylvania.; Mount Sinai Hospital, New York, New York., Elder B; Ohio State University, Columbus, Ohio., Kaptain G; John Theurer Cancer Center, Hackensack University, Hackensack, New Jersey., Cachia D; Medical University of South Carolina, Charleston, South Carolina., Moshel Y; Overlook Medical Center, Summit, New Jersey., Brem S; Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Piccioni D; University of California San Diego, San Diego, California., Landolfi J; JFK Medical Center, Edison, New Jersey., Chen CC; University of Minnesota, Minneapolis, Minnesota., Gruber H; Formerly Tocagen Inc, San Diego, California.; AmpiSwitch, San Diego, California., Rao AR; Formerly Tocagen Inc, San Diego, California.; Bionano Genomics, San Diego, California., Hogan D; Formerly Tocagen Inc, San Diego, California.; Impossible Foods, San Francisco, California., Accomando W; Formerly Tocagen Inc, San Diego, California.; Fate Therapeutics, San Diego, California., Ostertag D; Formerly Tocagen Inc, San Diego, California.; Abintus Bio, San Diego, California., Montellano TT; Formerly Tocagen Inc, San Diego, California.; Kura Oncology, San Diego, California., Kheoh T; Formerly Tocagen Inc, San Diego, California.; Mirati Therapeutics, San Diego, California., Kabbinavar F; Formerly Tocagen Inc, San Diego, California.; Puma Biotechnology, Los Angeles, California., Vogelbaum MA; Cleveland Clinic Foundation, Moffitt Cancer Center, Tampa, Florida.

Publikováno v: JAMA oncology [JAMA Oncol] 2020 Dec 01; Vol. 6 (12), pp. 1939-1946.

Clinical and Genomic Profile of Primary Cranial Neurolymphomatosis.

Autor: Wolf, Emily B (AUTHOR), Imperial, Robin (AUTHOR), Jiang, Liuyan (AUTHOR), Agarwal, Amit K (AUTHOR), Tun, Han W (AUTHOR)

Publikováno v: Journal of Blood Medicine. Jun2024, Vol. 15, p291-303. 13p.